BBIO News and Press, BridgeBio Pharma Inc. From 07/17/23

2023-07-17 09:09:09 ET The stock market has been on a solid upward trajectory recently, and the Nasdaq Composite (NASDAQINDEX: ^IXIC) has largely been leading the way. With so many stocks in high-growth areas like technology, the Nasdaq has been at the center of key trends driving s...

-   Highly statistically significant result observed on primary endpoint with a Win Ratio of 1.8 (p<0.0001) -   58% of ties in Finkelstein-Schoenfeld (F-S) primary analysis broken by all-cause mortality and frequency of cardiovascular-related hospitalization; statis...

2023-07-17 05:41:13 ET Stock futures were largely unchanged during Monday's premarket action ahead of a busy Q2 earnings season with releases from some of the world's most prominent companies , such as EV giant Tesla ( TSLA ), Goldman Sachs ( GS ), ...

2023-07-14 17:29:54 ET Gainers: BridgeBio Pharma ( NASDAQ: BBIO ) +15% . Greenidge Generation  ( GREE ) +5% . Conduent  ( CNDT ) +3% . The RealReal ( REAL ) +3% . Quantum-Si  ( QSI ) +3% . Losers: Ebix ...

PALO ALTO, Calif., July 14, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that members of its management team will host an investor call on Monday, July 17 at 8:00 a...

– Project ‘NADER’ is intended to span multiple phases, starting from mapping rare diseases in the UAE and wider region through innovative risk assessment algorithms, and moving towards clinical trials with transformative medicines ABU DHABI, United Arab Emirates a...

2023-07-09 18:15:18 ET Acumen Pharmaceuticals ( NASDAQ: ABOS ), Establishment Labs ( NASDAQ: ESTA ), Arcus Biosciences ( NYSE: RCUS ) and BridgeBio Pharma ( NASDAQ: BBIO ) are four of BTIG's top picks for small and mid-cap healthcare stocks going into the lat...

2023-07-07 07:44:52 ET BTIG technical strategist Jonanthan Krinsky is expecting a retracement for the broader market in the second half of the year following the strong gains so far. "If the year was over right now, it would be the NDX’s ( COMP.IND ) ( QQQ ) ninth best ye...

2023-06-27 07:00:00 ET Summary With the cost of living has increased dramatically, we're all seeking ways to increase our income. Getting double-digit yields with high-yield stocks is a risky proposition. However, exploiting human nature, we can safely generate higher yields w...

- Treatment with infigratinib at the Cohort 5 dose level resulted in a significant and robust increase in annual height velocity (AHV), with a mean change of +3.38 cm/year from baseline - 83% of children in Cohort 5 responded to infigratinib, as defined by an increase from basel...